To address this, we utilized pristane-induced lupus, a prototype IFN-driven systemic autoimmune disease model characterized by the production of high-titer autoantibodies against nucleic acid-associated antigens. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.